Aurobindo Pharma’s API unit in Telangana gets 2 US FDA observations

The inspection was carried out in Unit-V, an active pharmaceutical ingredient (API) manufacturing facility of Aurobindo arm Apitoria Pharma Private Ltd. Shares of Aurobindo Pharma Ltd ended at ₹1,212, down by ₹33, or 2.65%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *